Home » Topics » Regulatory

Regulatory
RSS

Gensia Sicor terminates collaboration with Atrix

Nov. 7, 1997

No Comments

Patient enrollment complete for phase II trial of memantine

Nov. 6, 1997

No Comments

FDA approves generic formulation of oxycodone/acetaminophen

Nov. 6, 1997

No Comments

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Nov. 3, 1997

No Comments

Clinical data reported for Actiq

Nov. 3, 1997

No Comments

FDA clears generic cimetidine

Oct. 29, 1997

No Comments

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

No Comments

FDA clears generic estradiol product

Oct. 29, 1997

No Comments

Cangene to manufacture new formulation of NABI's H-BIG

Oct. 28, 1997

No Comments

Effexor XR cleared by FDA

Oct. 28, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Gensia Sicor terminates collaboration with Atrix

Patient enrollment complete for phase II trial of memantine

FDA approves generic formulation of oxycodone/acetaminophen

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Clinical data reported for Actiq

FDA clears generic cimetidine

Pravachol now available in Canada for preventing a first heart attack

FDA clears generic estradiol product

Cangene to manufacture new formulation of NABI's H-BIG

Effexor XR cleared by FDA

Today's news in brief

Today's news in brief

Highfield Biopharmaceuticals files IND in China for immunoliposome HF-50 for solid tumors

Private labels, slow uptake mark first year of Humira biosimilars

Big pharma eyes China ‘at forefront of GLP-1 revolution’

Regulatory RSS

Regulatory
RSS